Ex-FTC Official Pans Claim Gilead-Teva Deal Hurt Competition
California federal jurors considering claims that pharmaceutical companies Gilead Sciences Inc. and Teva Pharmaceutical Industries Ltd. reached an illegal agreement to delay generic versions of HIV medications heard from a former...To view the full article, register now.
Already a subscriber? Click here to view full article